FdaApplication

NDA 219962

Back to search

Identifiers

Properties

PropertyValue
applicant_nameKENVUE BRANDS LLC
application_typeNDA
approval_date2026-07-24

Products (1)

ProductActive ingredientStrengthDosage form
TYLENOL WITH NAPROXENACETAMINOPHEN; NAPROXEN SODIUM325MG;110MGTABLET;ORAL

1 product